116 related articles for article (PubMed ID: 583231)
1. [Treatment of various types of hyperlipoproteinaemia with a combination of Mg-chlorophenoxy-isobutyrate and mesoinositol-hexanicotinate (author's transl)].
Bolzano K; Krempler F; Haslauer F
Arzneimittelforschung; 1979; 29(10):1621-4. PubMed ID: 583231
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Wilke H; Frahm H
Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study with a new antihyperlipemic combination].
Pistautz H
Arzneimittelforschung; 1977; 27(1):152-6. PubMed ID: 576816
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
5. [New drug combination for medical management of hyperlipemia: clinical study].
Fischer M; Falkensammer C
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of lipoproteinemia. Comparison between Lipo-Merz retard and a commercial combination drug].
Steger W
Fortschr Med; 1980 May; 98(18):(718-20). PubMed ID: 7390386
[TBL] [Abstract][Full Text] [Related]
7. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Artery; 1980; 8(2):113-9. PubMed ID: 7458676
[TBL] [Abstract][Full Text] [Related]
8. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb].
Kokot F; Szczechowska E
Z Gesamte Inn Med; 1981 Jul; 36(13):454-7. PubMed ID: 7025475
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Vorberg G; Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
Bucalossi A; Buzzelli G; D'Alessandro A
Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
[No Abstract] [Full Text] [Related]
12. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
Kaffarnik H; Schneider J; Schubotz R; Zöfel P; Hausmann L; Goebel KM
Artery; 1980; 8(6):537-46. PubMed ID: 6114725
[TBL] [Abstract][Full Text] [Related]
13. [Longterm therapy and etofibrate (author's transl)].
Kaffarnik H; Schneider J; Schubotz R; Zöfel P
MMW Munch Med Wochenschr; 1980 Jan; 122(3):95-8. PubMed ID: 6767931
[TBL] [Abstract][Full Text] [Related]
14. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Wechsler JG; Hutt V; Klör HU; Ditschuneit H
Artery; 1980; 8(6):519-29. PubMed ID: 7259531
[TBL] [Abstract][Full Text] [Related]
15. [Comparative double-blind investigation of bezafibrate and clofibrate in patients with primary hyperlipoproteinaemia].
Lageder H
Wien Klin Wochenschr; 1980 Feb; 92(3):95-101. PubMed ID: 6985560
[TBL] [Abstract][Full Text] [Related]
16. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
17. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hyperlipoproteinaemia in diabetic patients (author's transl)].
Bruneder H; Klein HJ
Dtsch Med Wochenschr; 1981 Dec; 106(49):1653-6. PubMed ID: 7308007
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with bezafibrate.
Schubotz R; Schneider J; Hausmann L; Mühlfellner G; Mühlfellner O; Kaffarnik H
Artery; 1980; 8(6):553-9. PubMed ID: 7259534
[TBL] [Abstract][Full Text] [Related]
20. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Dimroth H
Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
